CD8A and neoplasm: In vivo, DMTi treatment also enhanced MHC-I expression on tumor cells, while suppressing tumor growth and inducing an immunologic response as evidenced by enhanced CD8+ T cell infiltrate both on immunohistochemistry analysis and CD8+ immuno-PET (positron-emission tomography).